We are live on
!
Find out more
AAP
Arax Advisory Partners Portfolio holdings
AUM
$3.54B
1-Year Est. Return
19.14%
This Fund
S&P 500
This Quarter
Est. Return
+8.62%
1 Year Est. Return
+19.14%
3 Year Est. Return
+47.9%
5 Year Est. Return
+48.74%
10 Year Est. Return
–
AUM
$6.97B
AUM Growth
+$4.79B
(+220%)
Cap. Flow
+$6.91B
Cap. Flow
% of AUM
99.25%
Top 10 Holdings %
Top 10 Hldgs %
36.51%
Holding
4,400
New
1,371
Increased
1,984
Reduced
143
Closed
794
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P 100 ETF
OEF
|
+$2.43B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.24B |
| 3 |
DFAI
Dimensional International Core Equity Market ETF
DFAI
|
+$202M |
| 4 |
American Century Diversified Corporate Bond ETF
KORP
|
+$152M |
| 5 |
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
|
+$144M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Growth ETF
VUG
|
+$91.2M |
| 2 |
Vanguard Morningstar Value ETF
VTV
|
+$62.6M |
| 3 |
AXON
Axon Enterprise
AXON
|
+$58.1M |
| 4 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$46.5M |
| 5 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$44.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.48% |
| 2 | Financials | 8.05% |
| 3 | Industrials | 7.03% |
| 4 | Consumer Discretionary | 6.62% |
| 5 | Healthcare | 6.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2251
Dr. Reddy's Laboratories
RDY
$10.1B
| $20.6K | ﹤0.01% |
1,473
+558
| +61% | +$8.03K |
|
2252
GCM Grosvenor
GCMG
$813M
| $20.6K | ﹤0.01% |
+1,704
| New | +$21.1K |
|
|
ESPR
2253
DELISTED
Esperion Therapeutics
ESPR
| $20.5K | ﹤0.01% |
+7,750
| New | +$15K |
|
2254
ADMA Biologics
ADMA
$2.31B
| $20.5K | ﹤0.01% |
+1,399
| New | +$24K |
|
2255
Tejon Ranch
TRC
$450M
| $20.5K | ﹤0.01% |
1,280
+1,029
| +410% | +$17.9K |
|
2256
Business First Bancshares
BFST
$1.03B
| $20.4K | ﹤0.01% |
+866
| New | +$21.4K |
|
2257
Heritage Financial
HFWA
$1.21B
| $20.4K | ﹤0.01% |
842
+731
| +659% | +$17.7K |
|
2258
Kymera Therapeutics
KYMR
$8.62B
| $20.3K | ﹤0.01% |
+358
| New | +$16.1K |
|
2259
Aurora
AUR
$13.1B
| $20.1K | ﹤0.01% |
3,736
+2,606
| +231% | +$15.3K |
|
2260
GraniteShares 2x Short TSLA Daily ETF
TSDD
$31M
| $20.1K | ﹤0.01% |
2,000
| – | – |
|
2261
OR Royalties Inc
OR
$5.99B
| $20K | ﹤0.01% |
+500
| New | +$15.6K |
|
2262
Glacier Bancorp
GBCI
$6.36B
| $20K | ﹤0.01% |
410
+333
| +432% | +$15.6K |
|
|
SRTA
2263
Strata Critical Medical Inc
SRTA
$498M
| $19.9K | ﹤0.01% |
+3,939
| New | +$17.4K |
|
2264
Annexon
ANNX
$908M
| $19.9K | ﹤0.01% |
+6,530
| New | +$16.2K |
|
2265
Consolidated Water Co
CWCO
$479M
| $19.9K | ﹤0.01% |
+564
| New | +$18K |
|
2266
Symbotic
SYM
$5.15B
| $19.9K | ﹤0.01% |
369
-631
| -63% | -$31.9K |
|
2267
RBB Bancorp
RBB
$458M
| $19.8K | ﹤0.01% |
+1,056
| New | +$20.2K |
|
2268
Indivior Pharmaceuticals
INDV
$4.57B
| $19.8K | ﹤0.01% |
+821
| New | +$17.2K |
|
|
CCD
2269
Calamos Dynamic Convertible & Income Fund
CCD
$730M
| $19.6K | ﹤0.01% |
+933
| New | +$19.3K |
|
2270
Accuray
ARAY
$34M
| $19.6K | ﹤0.01% |
+11,729
| New | +$17.3K |
|
2271
American Express Global Business Travel
GBTG
$4.93B
| $19.6K | ﹤0.01% |
2,423
+1,519
| +168% | +$11.3K |
|
2272
Adeia
ADEA
$3.14B
| $19.5K | ﹤0.01% |
1,162
+861
| +286% | +$12.8K |
|
2273
VSE Corp
VSEC
$6.42B
| $19.4K | ﹤0.01% |
+117
| New | +$17.8K |
|
|
XIFR
2274
XPLR Infrastructure LP
XIFR
$1.08B
| $19.3K | ﹤0.01% |
1,902
+1,833
| +2,657% | +$17.7K |
|
2275
Clene
CLNN
$68.2M
| $19.3K | ﹤0.01% |
3,210
+2,140
| +200% | +$10.2K |
|
Similar funds
TYCC
TH
BCP
WWA
VPC
BPS
TCM
DILIC
Arax Advisory Partners's Q3 2025 Portfolio in Review
As of Q3 2025, Arax Advisory Partners held 4,400 positions worth $6.97B, up 220% from $2.18B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Arax Advisory Partners deployed $6.91B of net new capital in Q3 2025, opening 1,371 new positions and adding to 1,984 existing holdings. Its largest new stake was American Century Diversified Corporate Bond ETF: 3,224,236 shares worth $194M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 6.5% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Axon Enterprise, an estimated $58.1M trimmed.
- Arax Advisory Partners's largest Q3 2025 buy was American Century Diversified Corporate Bond ETF: 3,224,236 shares worth $194M.
- Arax Advisory Partners added most to iShares S&P 100 ETF in Q3 2025, an estimated $2.43B increase.
- Arax Advisory Partners's biggest Q3 2025 reduction was Axon Enterprise, cutting an estimated $58.1M.
- Arax Advisory Partners fully exited Vanguard Morningstar Growth ETF in Q3 2025, selling an estimated $91.2M.
- Arax Advisory Partners's ten largest holdings make up 37% of its $6.97B portfolio in Q3 2025.
- Arax Advisory Partners opened 1,371 new positions and closed 794 in Q3 2025.
- Arax Advisory Partners's portfolio value rose 220% quarter-over-quarter to $6.97B.
Based on Arax Advisory Partners's 13F filing for Q3 2025, filed 14 Nov 2025.